Why did Syrah Resources (ASX:SYR) share price jump 7% today?

The mineral and technology company has soared even higher today.

| More on:
A young man wearing glasses and a denim shirt sits at his desk and raises his fists and screams with delight.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Syrah Resources Ltd (ASX: SYR) share price has shot up again today off the back of its agreement with electric car giant, Tesla, Inc (NASDAQ: TSLA).

With no further news released today, the minerals and technology company appears to be basking in the afterglow of its significant deal.

At the close of trade today, the Syrah share price was up 6.83% at $1.80 apiece. This followed yesterday's lift of 3.3%. Let's take a closer look at the latest news.

What's the deal?

Last week, the company detailed an offtake agreement with Tesla in which it would supply natural graphite from its vertically integrated activity anode material (AAM) production facility in Vidalia, Georgia, in the United States.

Yesterday, the mineral and technology company gave more detail on the agreement, saying the collaboration would be subject to both parties agreeing to the final specifications of the offtake by no later than 31 December next year.

Under the terms, the product must be to Tesla's satisfaction by no later than 31 May 2025.

The agreement may also be subject to termination should the project not be up and running by exactly a year prior.

If satisfied with the above conditions, Tesla will offtake 8kt of expansion at Syrah's US facility per annum, which compares to the 10kt initially planned.

Syrah share price snapshot

This year has been a positive one for the Syrah share price, which has seen a massive jump of 87.5% since January.

Based on its current share price, the company has a market capitalisation of more than $897 million.

Motley Fool contributor Alice de Bruin has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »